Improving Obesity Health Outcomes via CB1 Inhibition
Skye Bioscience Chief Medical Officer, Puneet Arora, MD, MS, FACE, discusses how the body’s CB1 receptors modulate energy storage and use rather than just suppressing appetite, and may be important to achieve a healthier metabolic state.